Prevention of No-flow With Distal Protection Device in Patients Underwent Percutaneous Coronary Intervention175-178
Effects of Angiotensin Ⅱ and Valsartan on the Expression of ATR1/ATR2 Receptors, eNOS in Vascular Endothelial Cells188-192,208
Preliminary Survey on the Prevalence Rate of Hypertension in Patients with Dilated Cardiomyopathy199-202